19,100 Shares in Astrana Health, Inc. $ASTH Acquired by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 19,100 shares of the company’s stock, valued at approximately $468,000.

Other hedge funds have also bought and sold shares of the company. Royal Bank of Canada increased its stake in Astrana Health by 6.5% during the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after purchasing an additional 17,028 shares in the last quarter. AQR Capital Management LLC acquired a new stake in shares of Astrana Health during the first quarter worth $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Astrana Health by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock valued at $799,000 after buying an additional 1,263 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Astrana Health by 4,365.2% during the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock valued at $346,000 after buying an additional 10,913 shares during the last quarter. Finally, Intech Investment Management LLC increased its position in shares of Astrana Health by 5.8% in the 1st quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock valued at $1,383,000 after acquiring an additional 2,462 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Trading Down 1.6%

Shares of Astrana Health stock opened at $46.28 on Thursday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a fifty day moving average price of $39.85 and a 200 day moving average price of $30.21. Astrana Health, Inc. has a 1 year low of $18.08 and a 1 year high of $51.60. The stock has a market cap of $2.58 billion, a PE ratio of 75.87 and a beta of 0.89.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.29 by $0.45. The company had revenue of $965.10 million for the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The firm’s revenue was up 55.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.42 earnings per share. Equities research analysts predict that Astrana Health, Inc. will post 1.25 earnings per share for the current year.

Analyst Upgrades and Downgrades

ASTH has been the subject of a number of research analyst reports. BTIG Research restated a “buy” rating and issued a $50.00 target price on shares of Astrana Health in a research note on Tuesday, June 2nd. TD Cowen boosted their price target on Astrana Health from $35.00 to $45.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Truist Financial increased their price objective on Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a report on Thursday, May 14th. Weiss Ratings upgraded Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. Finally, Robert W. Baird set a $45.00 target price on Astrana Health in a report on Friday, May 8th. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Astrana Health has an average rating of “Moderate Buy” and a consensus price target of $45.00.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.